<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of the present study is to assess the roles of protein kinase C (PKC) isoforms, especially PKC delta and alpha, and 20-kD myosin light chain (MLC(20)) phosphorylation in the mechanism of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>We had shown that those PKC isoforms are involved in the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Using PKC isoform-specific inhibitors in a 'two- <z:mp ids='MP_0001914'>hemorrhage</z:mp>' canine model, we examined changes in the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, translocation of PKC isoforms and MLC(20) phosphorylation level in canine basilar arteries </plain></SENT>
<SENT sid="3" pm="."><plain>A PKC inhibitor (5 microM rottlerin for PKC delta or chelerythrine for PKC alpha) was injected into the cisterna magna on day 4 before the second <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The treatment was continued daily until day 7 </plain></SENT>
<SENT sid="5" pm="."><plain>Rottlerin inhibited the initial phase of vasospasm and PKC delta translocation, but did not significantly inhibit PKC alpha translocation </plain></SENT>
<SENT sid="6" pm="."><plain>Chelerythrine inhibited <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, and the translocation of both PKC delta and alpha throughout the entire course of the study </plain></SENT>
<SENT sid="7" pm="."><plain>Although <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after SAH was inhibited by each PKC inhibitor, the MLC(20) phosphorylation level remained elevated as in the untreated <z:mp ids='MP_0001914'>hemorrhage</z:mp>-control study </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following SAH depends on PKC delta and alpha, while the enhancement of MLC(20) phosphorylation contributes little to this form of vasospasm </plain></SENT>
</text></document>